ScreenerHero

PAHC Phibro Animal Health Corporation - Class A Common Stock

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · pahc.com
37.89USD+1.75%Mkt Cap: 1.51B $P/E: 15.33

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap1.51B USD
Enterprise Value2.22B USD
Revenue (TTM)1.52B USD
Gross Profit512.51M USD
Net Income (TTM)99.72M USD
Revenue/Share37.44 USD
Last Price37.89 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees2.6K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)15.33
P/E (Forward)9.67
PEG1.68
EV/EBITDA9.11
EV/Revenue1.46
P/S1.00
P/B3.92
EPS (TTM)2.43
EPS (Forward)3.85
52W Range
28.2530% of range60.08
52W High60.08 USD
52W Low28.25 USD
Profitability
Gross Margin33.76%
Oper. Margin10.64%
EBITDA Margin16.09%
Profit Margin6.57%
ROE25.87%
ROA6.64%
Growth
Revenue Growth4.80%
Earnings Growth24.60%
Cash Flow & Leverage
Operating CF68.95M USD
CapEx (TTM)59.09M USD
FCF Margin-1.27%
FCF Yield-1.28%
Net Debt711.66M USD
Net Debt/EBITDA2.91
Balance Sheet
Debt/Equity2.05
Current Ratio2.96
Quick Ratio1.02
Book Value/Sh9.50 USD
Cash/Share2.07 USD
Dividends
Fwd Div Rate0.48 USD
Trail. Div Rate0.48 USD
Div. Yield1.29%
5Y Avg Yield2.09%
Payout Ratio19.75%
Ex-Div DateSep 2, 2026
Pay DateSep 23, 2026
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)44.00 USD
Upside (mean)+16.1%
Target Range35.00 USD – 55.00 USD
35.00+16.1% to mean55.00
# Analysts4
Ownership
Shares Out.21.11M
Float20.91M
Insiders0.87%
Institutions103.96%
Short Interest
Short Ratio4.7d
Short % Float6.43%
Short % Out.2.81%
Shares Short1.14M
Short (prev mo.)1.23M
Technical
SMA 5035.79 (+5.9%)
SMA 20041.32 (-8.3%)
Beta0.47
S&P 52W Chg14.58%
Avg Vol (30d)229.02K
Avg Vol (10d)218.36K
Technical Indicators
RSI (14)58.9
MACD0.0384
MACD Signal-0.0305
MACD Hist.+0.0690
BB Upper39.49 USD
BB Middle36.23 USD
BB Lower32.97 USD
BB Width18.01%
ATR (14)1.376 USD
Vol Ratio (20d)0.88x